The clinical connection between the tumor and surrounding normal tissues of 73 HCC patients revealed that PRMT1 was strongly expressed in HCC and strongly linked with both ME2 methylation and poor clinical prognosis [51], which is consistent with our results. This evidence concerns the gene PRMT1 and hepatocellular carcinoma.